Illumina Inc. has announced global partnerships with top pharmaceutical companies for companion diagnostics (CDx) on Illumina’s TruSight Oncology (TSO) Comprehensive genomic profiling test. The collaboration focuses on KRAS alterations...
AbbVie, a global biopharmaceutical leader, hosted the National Conclave on World Retina Day at the India Habitat Centre, Delhi, which focused on Diabetic Macular Edema
Sanofi has declared a new $625 million multi-year capital commitment to its venture arm, Sanofi Ventures, bringing its total managed assets to over $1.4 billion. This is a considerable enlargement of the evergreen venture fund as it firmly...
Ipca Laboratories has made an accomplishment by signing a Technology Transfer and Joint Development Agreement that is definite with BioSimilar Sciences PR LLC (BSS).
Global Heart Hub and Novartis have put the spotlight on high Lipoprotein(a), or Lp(a), a genetic condition that is often overlooked that entails significant risk for cardiovascular disease such as heart attack and stroke...
Poly Medicure Ltd., a prominent medical device manufacturing company in India, has made public the signing of a conclusive agreement for the purchase of Medistream SA, the parent of Citieffe SRL
Gleneagles Hospital Mumbai, in collaboration with global healthcare technology leader Medtronic, hosted an exclusive medical conclave bringing together more than 100 doctors under one roof.The event highlighted the transformative Hub...
Glenmark Specialty S.A. (GSSA), a fully owned subsidiary of Glenmark Pharmaceuticals Ltd. (Glenmark), announced that it and Hengrui Pharma have signed an exclusive license and collaboration agreement for the next-generation HER2-targeting antibody
Apollo Hospitals Group is increasing its Genomics services to five additional locations, including Tier-2 cities such as Guwahati, Bhubaneswar, and Indore, to provide more access to genomic testing for the health needs of the country...
The Competition Commission of South Africa approved Torrent Pharmaceuticals' acquisition of a majority interest in JB Chemicals & Pharmaceuticals from international investment firm KKR on September 22, 2025, giving the company a major boost in its
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")